Booking1992 - 1998: Ha Noi Medical University.
2001 - 2003: Inje University - Korea.
2007 - 2012: Kyoto University - Japan.
Overview
PhD. MD. Le Thi Huong has 15 years experience in treatment of Internal Medicine, Respiratory, Tuberculosis, Immunology and Cancer, Infectious Disease.
Specialties
General practitioner
Services
- Consultation and Treatment of Internal Medicine, Respiratory, Tuberculosis, Immunology and Cancer, Infectious Disease;
- Especially, experience in counseling on Clinical Pharmacy, safety and effective use of drugs in the hospitals in the fields of Internal medicine, Surgery, Pediatric, Immunology and Cancer, Infectious Disease.
1999 - 2001: Lecturer and Doctor in Surgery Dept., Thai Nguyen University of Medicine and Thai Nguyen General Hospital;
2001 - 2003: Master course in Clinical Pharmacology, Inje University, Korea.
2003 - 2007: Lecturer and Doctor, Head of Clinical Pharmacy Dept., in Thai Nguyen University of Medicine and Thai Nguyen General Hospital;
2007 - 2012: Doctor course in Immunology and Cancer, Kyoto University, Japan. Supervisor: Prof. Tasuku Honjo (Nobel Prize in 2018);
2012 - 2015: Lecturer and Doctor, Vice Dean of Pharmacy Faculty, Thai Nguyen University of Medicine and Thai Nguyen General Hospital;
2015 - 2017: Doctor, Head of Request-Based Polyclinic Dept, Lung National Hospital.
2017 - now: Doctor in Outpatient Dept. in Vinmec International Hospital.
-
Huong LT, Mai NT. Drug - drug interaction in General Hospital. Journal of Military Medicine 2015 No 1; 98 - 116;
-
Huong LT, Nhung BT. Antibiotic Drug treatment in hospital- acquired pneumonia patient. Journal of Practical Medicine 2014 No 944; 234 - 240;
-
Huong LT, Nhung BT. Antibiotic drug and multidrug resistant. 2014. Journal of Practical Medicine No 944; 135 - 140;
-
Huong LT, Tinh NT. Paclitaxel and Cisplatin treatment in non-small cell cancer patient. Journal of Vietnamese Cancer Research. 2013 No 4; 78 - 84;
-
Huong LT, Nhung BT. Treatment of hypertension in patients with diabetes type 2. Journal of Vietnamese Cardiology. 2013. No 3; 67 - 74;
-
Huong le T, Kobayashi M, Nakata M, Shioi G, Miyachi H, Honjo T, Nagaoka H. In Vivo Analysis of Aicda Gene Regulation: A Critical Balance between Upstream Enhancers and Intronic Silencers Governs Appropriate Expression. PLoS One. 2013. Apr 16;8(4);
-
Qin H, Suzuki K, Nakata M, Chikuma S, Izumi N, Huong le T, Maruya M, Fagarasan S, Busslinger M, Honjo T, Nagaoka H. Activation-induced cytidine deaminase expression in CD4+ T cells is associated with a unique IL-10-producing subset that increases with age. PLoS One. 2011; 6(12);
-
Lee SS1, Lee SJ, Gwak J, Jung HJ, Thi - Le H, Song IS, Kim EY, Shin JG.Comparisons of CYP2C19 genetic polymorphisms between Korean and Vietnamese populations. Ther Drug Monit. 2007 Aug; 29(4): 455 - 9;
-
Lee SS, Kim SY, Kim WY, Thi-Le H, Yoon YR, Yea SS, Shin JG. MDR1 genetic polymorphisms and comparison of MDR1 haplotype profiles in Korean and Vietnamese populations.Ther Drug Monit. 2005 Aug; 27(4) 531-5;
-
Lee SS, Kim KM, Thi - Le H, Yea SS, Cha IJ, Shin JG. Genetic polymorphism of CYP2C9 in a Vietnamese Kinh population. Ther Drug Monit. 2005 Apr; 27(2);
-
Thi - Le H, Sang Seop Lee, Young Ran Yoon, In June Cha, Jae Gook Shin. Genetic polymorphism of cytochrome P450 2C19 in Vietnamese population. The Korea Society of Pharmacology (2002);
-
Sang Seop Lee, Jun Ho Lee, Thi - Le H, Young Ran Yoon, Jae Gook Shin. Genetic polymorphism of human MDR1 exon 21 and 26 mutant alleles in Korean and Vietnamese populations. The Korea Society of Pharmacology. 2002;
-
Thi - Le H, Sang Seop Lee, Young Ran Yoon, In June Cha, Jae Gook Shin Genetic polymorphism of cytochrome P450 2C19 in Vietnamese and Korean population. 14th International Symposium on Microsomes and Drug Oxidations (MD 2002) on July 2002. Sapporo, Japan;
-
Thi - Le H, Ji-Hong Shon, Kuyng - Ah Kim, Min - Jung Kim, Jae - Gook Shin, In - June Cha. Screening for the inhibitory potentials of second line tuberculosis drugs on Human CYPs. Journal of Korean Pharmacology. 2002 No 4; 201 - 208.
